Search research articles
Contact Us
Filters
Showing results (31-40 of 97) with videos related to
Page
of 10
Sort By:
Nucleic Acids Research
|
September 13, 2022
A toolkit for the identification of NEAT1_2/paraspeckle modulators
Haiyan An, Karen T Elvers, Jason A Gillespie, et al.
European Journal of Pharmacology
|
September 12, 2006
The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated
John R Atack, Peter J Bayley, Stephen R Fletcher, et al.
Psychopharmacology
|
December 31, 2010
Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys
Bradford D Fischer, John R Atack, Donna M Platt, et al.
ACS Pharmacology & Translational Science
|
March 20, 2025
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic Potential
Azeza M Fdel, Loren Waters, Ira Sharma, et al.
Journal of Neuroscience Methods
|
July 25, 2006
A comparative assessment of gamma-secretase activity in transgenic and non-transgenic rodent brain
Julian L Goggi, Huw D Lewis, Joanie Mok, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Negative allosteric modulation of α5-GABA <sub>A</sub> receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice
Fernanda Daher, Caio T Fukushima, Erik A Ingebretsen, et al.
Journal of Molecular Biology
|
May 4, 2019
The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
Ana-Caroline Raulin, Lucas Kraft, Youssra K Al-Hilaly, et al.
Schizophrenia Research
|
February 18, 2026
Novel positive allosteric modulators of alpha 5 subunit-containing GABA<sub>A</sub> receptors (α5-GABA<sub>A</sub>Rs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia
Daniela L Uliana, Mariana O Popa, Michael Paradowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors
Helen J Szekeres, John R Atack, Mark S Chambers, et al.
Neuropharmacology
|
December 19, 2003
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour
Ciara McCabe, David Shaw, John R Atack, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 97) with videos related to
Sort By:
Page
of 10
Nucleic Acids Research
|
September 13, 2022
A toolkit for the identification of NEAT1_2/paraspeckle modulators
Haiyan An, Karen T Elvers, Jason A Gillespie, et al.
European Journal of Pharmacology
|
September 12, 2006
The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated
John R Atack, Peter J Bayley, Stephen R Fletcher, et al.
Psychopharmacology
|
December 31, 2010
Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys
Bradford D Fischer, John R Atack, Donna M Platt, et al.
ACS Pharmacology & Translational Science
|
March 20, 2025
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic Potential
Azeza M Fdel, Loren Waters, Ira Sharma, et al.
Journal of Neuroscience Methods
|
July 25, 2006
A comparative assessment of gamma-secretase activity in transgenic and non-transgenic rodent brain
Julian L Goggi, Huw D Lewis, Joanie Mok, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Negative allosteric modulation of α5-GABA <sub>A</sub> receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice
Fernanda Daher, Caio T Fukushima, Erik A Ingebretsen, et al.
Journal of Molecular Biology
|
May 4, 2019
The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
Ana-Caroline Raulin, Lucas Kraft, Youssra K Al-Hilaly, et al.
Schizophrenia Research
|
February 18, 2026
Novel positive allosteric modulators of alpha 5 subunit-containing GABA<sub>A</sub> receptors (α5-GABA<sub>A</sub>Rs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia
Daniela L Uliana, Mariana O Popa, Michael Paradowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2004
3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors
Helen J Szekeres, John R Atack, Mark S Chambers, et al.
Neuropharmacology
|
December 19, 2003
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour
Ciara McCabe, David Shaw, John R Atack, et al.
Page
of 10